Related Experiment Video

Updated: Mar 1, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.5K

A practical guide to the use of eltrombopag in children with chronic immune thrombocytopenia

John D Grainger1, Sharon Thind1

  • 1a Royal Manchester Children's Hospital , Manchester , United Kingdom.

Pediatric Hematology and Oncology
|May 25, 2017
PubMed

Insights

Thrombopoietin receptor agonists (RAs) offer a new treatment for chronic immune thrombocytopenia (ITP) in children, potentially reducing bleeding risks. Eltrombopag is now approved for pediatric ITP, providing a valuable therapeutic option.

Area of Science:

  • Pediatric Hematology
  • Pharmacology

Background:

  • Pediatric immune thrombocytopenia (ITP) significantly impacts children and caregivers.
  • Thrombopoietin receptor agonists (TPO-RAs) are established treatments for adult chronic ITP (cITP).
  • Eltrombopag, a TPO-RA, is now approved for pediatric cITP in the US and Europe.

Purpose of the Study:

  • To review clinical data on TPO-RA efficacy and safety in pediatric ITP.
  • To provide recommendations for safe eltrombopag administration.
  • To discuss future management strategies for pediatric ITP.

Main Methods:

  • Evaluation of clinical data on TPO-RAs in pediatric ITP.
  • Review of safety and efficacy studies.
  • Analysis of treatment guidelines and future research directions.

Main Results:

  • Eltrombopag has demonstrated efficacy in pediatric ITP.
  • TPO-RAs may reduce bleeding events and reliance on other therapies.
  • Key recommendations for safe eltrombopag use are outlined.

Conclusions:

  • TPO-RAs, particularly eltrombopag, represent a significant advancement in treating pediatric ITP.
  • Safe administration protocols are crucial for optimal outcomes.
  • Further research will refine long-term management strategies.
Abstract

Keywords:
Eltrombopagpediatricromiplostimthrombocytopeniathrombopoietin receptor agonists

More Related Videos

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

608
Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

9.3K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
341
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392